Dr. Ausbüttel Pharma GmbH
Pharmaceutical Companies · Dortmund
Dr. Ausbüttel Pharma GmbH is a pharmaceutical company based in Dortmund, North Rhine-Westphalia, Germany. The company operates in the German pharmaceutical market and is regulated by the BfArM (Federal Institute for Drugs and Medical Devices).
Content in German
The detailed company information on this page is provided in the original German language. You can use your browser's built-in translation feature to view it in English.
Right-click on the page and select "Translate to English" or use the translation icon in your browser's address bar.
Dr. Ausbüttel Pharma GmbH Overview
Dr. Ausbüttel Pharma GmbH is a pharmaceutical company based in Dortmund, Nordrhein-Westfalen. The company operates in the German pharmaceutical market and is regulated by the BfArM (Federal Institute for Drugs and Medical Devices).
Activities & Products
Pharmaceutical companies such as Dr. Ausbüttel Pharma GmbH develop, produce or distribute medicines for the German and international market. All authorised products are subject to approval and are regulated by BfArM or the European Medicines Agency (EMA).
Location & Contact
Dr. Ausbüttel Pharma GmbH can be reached at the following address: Ernt-Abbe-Straße 4, 44149 Dortmund – Phone: 0231222450. For current information and enquiries, please contact the company directly.
More information: Pharmaunternehmen in Nordrhein-Westfalen or all Pharmaunternehmen in Germany on Sanoliste.
Pharmazeutische Regulierung in Deutschland
Pharmaceutical companies such as Dr. Ausbüttel Pharma GmbH are subject to one of the world's most stringent regulatory frameworks in Germany. The German Medicinal Products Act (AMG) governs the authorisation, manufacturing, distribution and monitoring of medicinal products. Market authorisation for new active substances falls under the responsibility of either the Federal Institute for Drugs and Medical Devices (BfArM) or the European Medicines Agency (EMA), depending on whether a national or centralised authorisation is sought.
Arzneimittelversorgung & Marktumfeld
With a revenue volume exceeding 50 billion euros, the German pharmaceutical market is one of the largest in Europe. Dr. Ausbüttel Pharma GmbH, based in Dortmund, is part of this market. The supply chain from manufacturer through wholesaler to pharmacy is governed by Good Manufacturing Practice (GMP) and Good Distribution Practice (GDP). Since the entry into force of the Act for Greater Safety in the Medicinal Products Supply (GSAV), stricter requirements for the traceability of medicinal products also apply.
Pharmastandort Nordrhein-Westfalen
Nordrhein-Westfalen is a significant pharmaceutical location in Germany. Companies such as Dr. Ausbüttel Pharma GmbH benefit from proximity to research institutions, university hospitals and well-developed infrastructure. The industry employs over 140,000 people in Germany and invests billions annually in research and development.
Frequently asked questions about Dr. Ausbüttel Pharma GmbH
What does Dr. Ausbüttel Pharma GmbH do?
Dr. Ausbüttel Pharma GmbH is ein Hersteller of productsn for the professionelle Wandversorgung. Sterile and unsterile Wandverbände, Kompressen, Fixierbinden, idealfeuchte Wandverbände and kindgerechte Pflaster finden sich im Sortiment. Für the Okklusionstherapie wurde ein spezielles Pflaster develops.
What medicines does Dr. Ausbüttel Pharma GmbH manufacture?
Dr. Ausbüttel Pharma GmbH is a pharmaceutical company in Dortmand. Überblick about Dr. Ausbüttel Pharma GmbH Dr. Ausbüttel Pharma GmbH is ein renommiertes and innovatives Familienundernehmen, the seinen Sitz in Dortmand, Deutschland hat. Das Unte Alle in Germany zugelassenen medicines are in the medicines-Datenbank des BfArM recherchierbar.
How are medicines approved in Germany?
Neue medicines benötigen vor dem Inverkehrbringen eine Zulassung durch the BfArM (national) or the EMA (europaweit). Der Zulassungsprozess umfasst the Prüfung of quality, Wirksamkeit and Unbedenklichkeit on Basis präklinischer and klinischer Stuthen. Die Nutzenbewertung after § 35a SGB V entscheidet about the Erstattung durch the gesetzlichen Krankenkassen.
What does GMP mean in pharmaceutical production?
GMP (Good Manufacturing Practice) bezeichnet the Gute manufacturingspraxis – ein System of qualitysstandards, the sicherstellt, thes medicines gleichbleibend after den gefortheten qualitysnormen hergestellt and geprüft are. Die GMP-Richtlinien are in the EU durch den EudraLex Volume 4 definiert.
Pharmaceutical Companies in Germany
Related areas in healthcare
Pharmaceutical Companies in Nordrhein-Westfalen
All Pharmaceutical Companies in Nordrhein-Westfalen on Sanoliste — or discover all categories by federal state.